Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

Why Do Cancer Cells Become “Addicted” to Oncogenic Epidermal Growth Factor Receptor?

  • Ingo Mellinghoff
  • Published: October 30, 2007
  • DOI: 10.1371/journal.pmed.0040321

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations

Daniel B Costa, Balázs Halmos, Amit Kumar, Susan T Schumer, Mark S Huberman, Titus J Boggon, Daniel G Tenen, Susumu Kobayashi
Research Article | published 30 Oct 2007 | PLOS Medicine
doi:10.1371/journal.pmed.0040315

Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 Mimetics

Mark S Cragg, Junya Kuroda, Hamsa Puthalakath, David C. S Huang, Andreas Strasser
Research Article | published 30 Oct 2007 | PLOS Medicine
doi:10.1371/journal.pmed.0040316

Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas

Yixuan Gong, Romel Somwar, Katerina Politi, Marissa Balak, Juliann Chmielecki, Xuejun Jiang, William Pao
Research Article | published 9 Oct 2007 | PLOS Medicine
doi:10.1371/journal.pmed.0040294